Retinoic acid and cancer treatment

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Retinoic acid (RA) is a key metabolite of vitamin A.
• RA plays crucial roles in cellular development, differentiation, and has demonstrated anti-cancer properties.
• RA has shown suppressive effects on various cancers, including lung, prostate, breast, ovarian, bladder, oral, and skin cancers.

Purpose of the Study:

• To review and synthesize existing evidence on the role of retinoic acid in cancer.
• To elucidate the molecular mechanisms by which RA influences cancer cell fate.
• To explore the potential of RA as a therapeutic agent and dietary supplement for cancer prevention and treatment.

Main Methods:

• Literature review of studies investigating retinoic acid's effects on cancer cells.
• Analysis of data on dose-dependent effects of RA (low vs. high doses).
• Examination of the involvement of cell cycle regulators like p27 and Cdk5.

Main Results:

• Low doses of retinoic acid induce cell cycle arrest in cancer cells.
• High doses of retinoic acid promote apoptosis (programmed cell death) in cancer cells.
• The proteins p27 and Cdk5 are implicated in mediating RA's anti-cancer effects.

Conclusions:

• Retinoic acid's molecular mechanisms can effectively control cancer cell fate.
• RA shows potential for cancer prevention and therapy, particularly as a dietary supplement.
• Further research into RA for cancer is warranted, considering its dose-dependent effects and potential cytotoxicity at high concentrations.